/Companies

Nephris

1 known investors

Find your way into Nephris

Sign up to see every warm intro you have to Nephris

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Nephris team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Nephris is a biotech company developing first-in-class therapies for diabetic chronic kidney disease. It focuses on research and innovation for patients with diabetic renal disease.

Investors · 1

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Frequently asked questions

What does Nephris do?
Nephris is a biotech company developing first-in-class therapies for diabetic chronic kidney disease. It focuses on research and innovation for patients with diabetic renal disease.
Who are Nephris's investors?
Nephris's investors include Sofinnova Partners.